Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 4,675,016
- Share change
- +264,988
- Total reported value
- $21,738,469
- Price per share
- $4.65
- Number of holders
- 32
- Value change
- +$1,170,257
- Number of buys
- 19
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
13%
|
3,596,680
|
$27,155,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.67%
|
189,969
|
$1,435,000 | — | 30 Sep 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.53%
|
150,000
|
$1,133,000 | — | 30 Sep 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
145,000
|
$1,095,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.47%
|
133,747
|
$1,010,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
43,920
|
$331,000 | — | 30 Sep 2017 | |
| Destination Wealth Management |
13F
|
Company |
0.1%
|
29,656
|
$224,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
22,016
|
$166,000 | — | 30 Sep 2017 | |
| Family Manage LLC |
13F
|
Company |
0.07%
|
20,550
|
$155,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
17,052
|
$129,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
15,700
|
$119,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
9,863
|
$75,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
7,393
|
$56,000 | — | 30 Sep 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
6,400
|
$48,000 | — | 30 Sep 2017 | |
| STRS OHIO |
13F
|
Company |
0.02%
|
4,600
|
$34,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.01%
|
4,250
|
$32,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
3,721
|
$28,000 | — | 30 Sep 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
2,413
|
$18,000 | — | 30 Sep 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
2,115
|
$16,000 | — | 30 Sep 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
1,894
|
$14,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
685
|
$6,000 | — | 30 Sep 2017 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$5,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
563
|
$4,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
549
|
$4,000 | — | 30 Sep 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
351
|
$2,650 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
268
|
$2,000 | — | 30 Sep 2017 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
210
|
$2,000 | — | 30 Sep 2017 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
316
|
$1,000 | — | 30 Sep 2017 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
112
|
$1,000 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
91
|
$1,000 | — | 30 Sep 2017 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
|
Company |
0%
|
80
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q4 2017
As of 31 Dec 2017,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,675,016 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, Vanguard Group Inc, BlackRock Inc., Artal Group S.A., BRIDGEWAY CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, Destination Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, and MORGAN STANLEY.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
28
Q4 2017 holders
32
Holder diff
4
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.